Excision of Hyperplastic Tissue, per Arch Template

Excision of hyperplastic tissue - per arch.

RMH: Medical history reviewed/updates
Vitals: BP/pulse; other vitals if indicated

Arch: Arch
Site: Site/tooth area
Tissue description: Tissue description
Size: Size
Duration: Duration
Indication: Indication/diagnosis
Radiographs/images: Radiographs/images reviewed/taken and findings
Prosthesis fabrication.
Tissue overgrowth from ill-fitting denture.

Consent: Consent/PARQ reviewed; signed/verbally obtained

Anesthesia: Anesthetic used
Carps: Carpules/amount

Surgical procedure support: Specific site/teeth, indication, and medical necessity
Operative details: Surgical access, tissue/bone removed or repositioned, closure materials
Image/specimen support: Radiographs/photos/specimen/lab as applicable

Procedure:
Hyperplastic tissue outlined.
Tissue excised.
Specimen submitted to pathology.
Underlying tissue evaluated.
Wound edges approximated.
Sutured with: Suture material/size
Hemostasis achieved.

Complications: None or describe.

Patient tolerance: Tolerance/response.

Post-op instructions: Instructions reviewed.
Adjust/remake denture before wearing.
Rx: Prescription or none

Pathology results to be discussed at follow-up.

NV: Next visit

Documentation requirements

D7970 lives in the carrier "always-review" tier alongside D7971, D7972, and the pre-prosthetic alveoloplasty codes — first claims rarely auto-pay without a narrative that ties the excision to a prosthetic problem and rules out a biopsy. The chart note has to prove three things at once: the tissue was redundant / hyperplastic and chronically irritated, the indication was prosthetic (or otherwise medically necessary), and the work was a true excision — not a small-area biopsy, not pericoronal gingiva, not a frenectomy. A defensible note includes:

• Arch and site(s) — explicit "maxillary arch" or "mandibular arch" (and "bilateral arches" only when excising in both, billed as two D7970 line items, one per arch). Within the arch, the specific anatomic sites of the hyperplastic folds — labial vestibule from canine to canine, buccal vestibule right premolar region, palatal mucosa across hard palate, etc. Site-specific detail anchors the claim to per-arch reporting and rules out a same-DOS overlap with D7971 (pericoronal) or D7972 (tuberosity).
• Tissue description — explicit description of the tissue: number and size of folds, color (typically pink-to-erythematous), texture (firm, fibrous, mobile flap of mucosa), location relative to the denture flange or prosthesis margin, presence or absence of ulceration, induration, asymmetry, fixed base. The description distinguishes benign denture-induced hyperplasia (mobile, fibrous, erythematous-but-not-indurated, history of long-standing ill-fitting denture) from a lesion of concern that warrants biopsy first.
• Size — measured in mm or cm in greatest dimension and number of distinct folds (e.g., "two parallel folds of hyperplastic tissue along maxillary anterior labial vestibule, 25 mm and 18 mm in length, ~5 mm in height"). Size matters because carriers cross-check against D7410 / D7411 (benign lesion excision <1.25 cm vs ≥1.25 cm) when the description suggests a discrete neoplasm rather than diffuse hyperplasia.
• Duration / chronicity — how long the lesion has been present, history of denture wear (years in current prosthesis, last reline / rebase / remake date), patient's awareness of the tissue. "Long-standing fold of redundant tissue, present for 3+ years according to patient, denture last relined 8 years ago" is the prototype narrative for epulis fissuratum.
• Indication / diagnosis — the pre-prosthetic narrative is the single most important sentence in the note. Examples: "Denture-induced fibrous hyperplasia (epulis fissuratum) maxillary anterior labial vestibule; excision required prior to fabrication of new complete maxillary denture (D5110, planned)," "Inflammatory papillary hyperplasia of hard palate, maxillary arch; excision required prior to reline of existing complete maxillary denture (D5750)," "Generalized hyperplastic ridge tissue maxillary arch interfering with planned partial denture (D5213, planned) path of insertion." Tie the excision explicitly to the planned prosthesis or reline.
• Radiographic / imaging review — pre-op panoramic or PA to confirm there is no underlying bony pathology mimicking soft-tissue overgrowth (peripheral giant cell granuloma, peripheral ossifying fibroma can present similarly), no retained roots driving inflammation, and no foreign body. Intraoral photographs labeled with date and site are routine and increasingly expected by carriers, especially for first-time D7970 claims.
• Consent / PARQ — counseled on the procedure, alternatives (no excision and continued prosthetic compromise, biopsy-first if any concern about the tissue, OMS referral for extensive cases, laser vs scalpel vs electrocautery), risks: bleeding, infection, scarring with possible vestibular shortening (a real concern for epulis fissuratum — aggressive excision without vestibuloplasty can leave a shallow vestibule that compromises the new denture), recurrence if the prosthesis is not adjusted or remade, paresthesia in the area, delayed healing, possibility that pathology returns an unexpected diagnosis requiring further treatment. Note signed vs verbal consent.
• Anesthesia — agent, concentration, vasoconstrictor, technique (local infiltration along the planned excision line is typical; bilateral infraorbital + greater palatine for full-arch maxillary work; bilateral mental + lingual infiltration for mandibular vestibule), carpule count.
• Operative detail — instrument used (scalpel #15 blade, electrocautery, diode laser, CO2 laser, radiosurgery — name it), incision design (elliptical excision around the redundant tissue, wedge excision, or stripping technique for diffuse hyperplasia), depth (mucosa and submucosa down to but not into periosteum — staying supraperiosteal preserves vestibular depth and is a key technique point for epulis fissuratum), hemostasis method (electrocautery, pressure, hemostatic agent, sutures), closure (primary closure with resorbable suture vs healing by secondary intention vs periosteal stabilization with sutures to a stent or denture lined with tissue conditioner — a recognized technique to maintain vestibular depth). Document everything explicitly.
• Specimen handling — pathology submission — for typical denture-induced epulis fissuratum that is clinically obvious and benign-appearing, specimen submission is recommended but not mandatory in all jurisdictions. For any lesion that is asymmetric, indurated, ulcerated, fixed to underlying tissue, atypical in color, or that the clinician has any uncertainty about, the specimen must be submitted to pathology with a clinical history and differential. Document the lab / pathologist receiving the specimen, the specimen label, the chain of custody, and the date results are expected. "Specimen submitted to [Lab Name] for histopathologic evaluation; results pending; will discuss with patient at follow-up" is the defensible language. Many state boards and risk-management guidelines recommend submitting all excised oral soft tissue regardless of clinical certainty — when in doubt, submit.
• Hemostasis — explicit statement; vestibular tissues are vascular and bleeding from labial / facial vessels is a known consideration.
• Complications — explicit "None" or describe (bleeding controlled with electrocautery, anticipated vestibular shortening discussed pre-op, intraoperative finding requiring change in plan).
• Patient tolerance / response — tolerated well, vitals stable, ambulatory dismissal.
• Post-op instructions — soft diet, no denture wear over surgical site for 1–2 weeks (or, alternatively, denture relined with tissue conditioner immediately and worn as a stent — practice-dependent technique), saline rinses starting 24 hours post-op, chlorhexidine rinse for hygiene, avoid trauma, return precautions for excessive bleeding, swelling, fever, foul taste. Counsel that the existing denture must be adjusted, relined, or remade before being worn again, otherwise the hyperplasia will recur.
• Rx — analgesic (ibuprofen 600 mg PO q6h PRN ± acetaminophen), antibiotic typically not required for routine D7970 unless extensive excision or immunocompromise (amoxicillin 500 mg PO TID x 5 days when indicated; clindamycin if PCN-allergic), chlorhexidine 0.12% rinse BID x 7 days. Document drug, dose, route, frequency, duration, counseling.
• Pathology follow-up plan — explicit statement that pathology results will be discussed at the follow-up visit, and the plan if results return atypical (re-excision, referral, additional imaging). This sentence protects the practice if the unexpected dysplasia / carcinoma diagnosis comes back.
• Next visit — typical 1–2 week post-op for healing check and pathology review; longer-interval recall before denture impressions (commonly 3–6 weeks of soft-tissue maturation before the master impression for D5110 / D5120 / partial, or 4–6 weeks before reline).
• Provider signature and any auxiliary operator initials.

Two patterns to avoid: (a) charting D7970 as "hyperplastic tissue removed" with no pre-prosthetic indication, no measurement, no specimen disposition — auditors flag any D7970 without a planned prosthesis, reline, or chronic-irritation history as either a miscoded biopsy (D7286) or a miscoded benign-lesion excision (D7410 / D7411); (b) billing D7970 per fold rather than per arch — the code is per arch regardless of how many separate folds are excised, and unit-counted submissions get re-coded down on review.

Common denial reasons

The most frequent reasons D7970 is denied, downgraded, or recouped:

• No documented prosthetic plan. The single largest denial bucket. D7970 without a planned D5110 / D5120 / D5130 / D5140 / D5213 / D5214 / reline (D5730–D5761) / rebase (D5710–D5721) on the treatment plan or in the patient's recent claim history reads as cosmetic or non-medically-necessary and gets denied.
• Denture not yet authorized (Medicaid). State Medicaid programs and several MCOs require denture approval before pre-prosthetic surgery. Submitting D7970 first, expecting the denture to follow, regularly results in the practice eating the surgery fee.
• Billed per fold rather than per arch. D7970 is per arch regardless of the number of separate hyperplastic folds excised. Unit-counted submissions get paid as a single arch or denied as documentation error.
• No pre-op size measurement or photographic documentation. Notes that read "hyperplastic tissue excised" without dimensions, fold count, or pre-op photographs read as either a small biopsy miscoded as D7970 or insufficient documentation.
• No specimen disposition documented. Operative notes that don't state whether the specimen was submitted to pathology (and to which lab, with what label, and when results are expected) get flagged. State boards and risk-management guidelines increasingly expect submission of all excised oral soft tissue; absence of submission documentation is a malpractice and audit concern.
• Specimen not submitted on a clinically suspicious lesion. When the operative note describes an asymmetric, indurated, ulcerated, or atypical lesion and pathology was not submitted, carriers and risk-management reviewers flag the case. The defensible default for any non-routine lesion is biopsy first (D7286), pathology, then planned excision once benignity is confirmed.
• Miscoded biopsy. A small (<1 cm) excision of a discrete lesion submitted for diagnostic histology is D7286 (incisional or excisional biopsy of soft tissue), not D7970. Carriers re-code based on the operative note describing a biopsy procedure.
• Miscoded benign-lesion excision. A discrete fibroma, papilloma, or lipoma excised from oral soft tissue is D7410 / D7411 / D7412 / D7413 / D7414 (excision of benign lesion, by size and complexity), not D7970. D7970 is reserved for diffuse, prosthesis-induced redundant tissue.
• Miscoded pericoronal gingiva. Hyperplastic operculum or distal-wedge gingiva at a partially erupted or recently extracted molar is D7971, not D7970. Anatomic mismatch; re-coded.
• Miscoded fibrous tuberosity. Discrete fibrous overgrowth of the maxillary tuberosity is D7972, not D7970. Site-specific code; re-coded.
• Miscoded frenectomy. Aberrant frenum attachment excised is D7960 / D7961 / D7962 / D7963, not D7970. Re-coded.
• Miscoded gingivectomy. Periodontal pocket reduction or aesthetic crown lengthening is D4210 / D4211 / D4249, not D7970. Re-coded.
• Default-template chart note. Identical D7970 narrative across patients, no patient-specific size, no photographs, no specimen disposition. Medicaid MCO recoupment programs flag template-fingerprint patterns.
• No counseling on denture adjustment / replacement. Auditors view absence of post-op denture counseling as evidence the procedure won't durably resolve the indication, calling medical necessity into question.
• Missing operator signature / initials. Auto-flagged by automated audit systems.

Related templates